David Kloecker
0000-0002-8910-2091
11 papers found
Refreshing results…
Translating trial results into interpretable risk estimates: Systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Comment on Baranova et al. Causal Associations Between Basal Metabolic Rate and COVID-19. Diabetes 2023;72:149–154
Intensive glucose control and recurrent cardiovascular events: 14‐year follow‐up investigation of the ACCORDION study
Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes
Association Between Accelerometer-Assessed Physical Activity and Severity of COVID-19 in UK Biobank
Cardiovascular effects of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: The P value and beyond
Patterns of Multimorbidity and Risk of Severe SARS-CoV-2 Infection: an observational study in the U.K
Association of Timing and Balance of Physical Activity and Rest/Sleep With Risk of COVID-19: A UK Biobank Study
Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis
Efficacy and tolerability of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A systematic review and network meta‐analysis
Efficacy of low‐ and very‐low‐energy diets in people with type 2 diabetes mellitus: A systematic review and meta‐analysis of interventional studies
Missing publications? Search for publications with a matching author name.